Literature DB >> 9703442

Strategies for analyzing nerve conduction data: superiority of a summary index over single tests.

L R Robinson1, P J Micklesen, L Wang.   

Abstract

We compared three strategies for diagnosing carpal tunnel syndrome: using a single test; requiring one, two, or three of three tests to be abnormal; or utilizing a single summary variable incorporating data from three tests. Sixty-five hands of subjects without clinical carpal tunnel syndrome (CTS) were compared with 66 hands with clinical CTS. Three latency differences were measured: median-ulnar (8 cm) midpalmar orthodromic (palmdiff); median-ulnar ring finger (14 cm) antidromic (ringdiff); and median-radial thumb (10 cm) antidromic (thumbdiff). The combined sensory index (CSI) was the sum of these three differences. Sensitivity for the tests was palmdiff 69.7%, ringdiff 74.2%, thumbdiff 75.8%, and CSI 83.1%. Specificity was 95.4-96.9%. Requiring one, two, or three of three tests to be abnormal yielded sensitivities of 84.8%, 74.2%, or 56.1%, respectively, but specificities of 92.3%, 98.5%, and 100%, respectively. We conclude that a combined index improves diagnostic classification over use of single test results.

Entities:  

Mesh:

Year:  1998        PMID: 9703442     DOI: 10.1002/(sici)1097-4598(199809)21:9<1166::aid-mus7>3.0.co;2-5

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  A randomized sham-controlled trial of a neurodynamic technique in the treatment of carpal tunnel syndrome.

Authors:  Joel E Bialosky; Mark D Bishop; Don D Price; Michael E Robinson; Kevin R Vincent; Steven Z George
Journal:  J Orthop Sports Phys Ther       Date:  2009-10       Impact factor: 4.751

Review 2.  Evaluation of work-related carpal tunnel syndrome.

Authors:  Robert A Werner
Journal:  J Occup Rehabil       Date:  2006-06

3.  Neurophysiological testing correlates with clinical examination according to fibre type involvement and severity in sensory neuropathy.

Authors:  J-P Lefaucheur; A Créange
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

4.  Computer protocol for the electrodiagnostic evaluation of patients with suspected median neuropathy at the wrist.

Authors:  Simon Podnar; Milan Grgič
Journal:  Neurol Sci       Date:  2013-05-21       Impact factor: 3.307

5.  The effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort study.

Authors:  J W Albers; D H Garabrant; S J Schweitzer; R P Garrison; R J Richardson; S Berent
Journal:  Occup Environ Med       Date:  2004-03       Impact factor: 4.402

6.  Randomized clinical trial of surgery versus conservative therapy for carpal tunnel syndrome [ISRCTN84286481].

Authors:  Brook I Martin; Linda M Levenson; William Hollingworth; Michel Kliot; Patrick J Heagerty; Judith A Turner; Jeffrey G Jarvik
Journal:  BMC Musculoskelet Disord       Date:  2005-01-18       Impact factor: 2.362

7.  Effects of varying case definition on carpal tunnel syndrome prevalence estimates in a pooled cohort.

Authors:  Matthew S Thiese; Fred Gerr; Kurt T Hegmann; Carisa Harris-Adamson; Ann Marie Dale; Bradley Evanoff; Ellen A Eisen; Jay Kapellusch; Arun Garg; Susan Burt; Stephen Bao; Barbara Silverstein; Linda Merlino; David Rempel
Journal:  Arch Phys Med Rehabil       Date:  2014-08-28       Impact factor: 3.966

8.  Finding relief at the end of the (Carpal) tunnel: Electrophysiological clues.

Authors:  Chun Wai Yip; Yew Long Lo
Journal:  J Neurosci Rural Pract       Date:  2013-10

9.  Determination of Electrophysiologically Moderate and Severe Carpal Tunnel Syndrome: Ultrasonographic Measurement of Median Nerve at the Wrist.

Authors:  Chanwit Phongamwong; Narathorn Soponprapakorn; Wipoo Kumnerddee
Journal:  Ann Rehabil Med       Date:  2017-08-31

Review 10.  Clinical and electrophysiological evaluation of carpal tunnel syndrome: approach and pitfalls.

Authors:  Mohammed H Alanazy
Journal:  Neurosciences (Riyadh)       Date:  2017-07       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.